ZIMMER BIOMET HOLDINGS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Zimmer Biomet Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Zimmer Biomet Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$18.9M, a 134% decline year-over-year.
  • Zimmer Biomet Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$52.7M, a 123% decline year-over-year.
  • Zimmer Biomet Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $42.2M, a 62.4% decline from 2022.
  • Zimmer Biomet Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $112M, a 110% increase from 2021.
  • Zimmer Biomet Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $53.5M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$52.7M -$18.9M -$75.3M -134% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $22.6M $59.1M -$7.8M -11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $30.4M $42.3M -$11.8M -21.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $42.2M -$135M -$191M -344% Oct 1, 2023 Dec 31, 2023 8-K 2024-08-07
Q3 2023 $233M $56.4M +$73M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $160M $66.9M +$21.4M +47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $138M $54.1M +$26.1M +93.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $112M $55.4M +$84.6M Oct 1, 2022 Dec 31, 2022 8-K 2024-08-07
Q3 2022 $27.7M -$16.6M -$44.9M -159% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $72.6M $45.5M +$12.2M +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $60.4M $28M +$6.9M +32.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $53.5M -$29.2M +$68M +70% Oct 1, 2021 Dec 31, 2021 8-K 2024-08-07
Q3 2021 -$14.5M $28.3M +$18.6M +192% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$33.1M $33.3M +$47M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$80.1M $21.1M +$15.9M +306% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$96M -$97.2M -$52.7M -118% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$43.3M $9.7M +$257M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$300M -$13.7M -$22.1M -263% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$278M $5.2M -$40.3M -88.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$238M -$44.5M -$81.1M -222% Oct 1, 2019 Dec 31, 2019 8-K 2022-06-22
Q3 2019 -$157M -$247M -$239M -2811% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $82M $8.4M -$24.5M -74.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $107M $45.5M -$1.7M -3.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $108M $36.6M +$1.39B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-22
Q3 2018 -$1.28B -$8.5M -$36.9M -130% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$1.25B $32.9M +$20.6M +167% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$1.27B $47.2M +$81.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$1.35B -$1.36B -$1.32B -3384% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 -$32.3M $28.4M +$82.8M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$115M $12.3M -$130M -91.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $14.8M -$34.1M -$80.2M -174% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $95M -$38.9M -$45.4M -698% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $140M -$54.4M -$64M -667% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $204M $142M +$207M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$2.6M $46.1M -$9.6M -17.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $7M $6.5M -$31.7M -83% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $38.7M $9.6M -$47.3M -83.1% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $86M -$64.8M -$125M -207% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $211M $55.7M -$9.1M -14% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $220M $38.2M -$37M -49.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $257M $56.9M +$12.6M +28.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $245M $60.3M +$16M +36.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $229M $64.8M -$900K -1.37% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $230M $75.2M +$41M +120% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $189M $44.3M -$12.9M -22.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $201M $44.3M -$29.3M -39.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $231M $65.7M -$6.5M -9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 $237M $34.2M +$1.8M +5.56% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-23
Q3 2012 $235M $57.2M -$6.5M -10.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $242M $73.6M +$28.1M +61.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $214M $72.2M -$5.1M -6.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $219M $32.4M -$42.2M -56.6% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $261M $63.7M -$2.6M -3.92% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $264M $45.5M -$2.8M -5.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $267M $77.3M +$3.2M +4.32% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 $263M $74.6M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $66.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 $48.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $74.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.